T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice

102Citations
Citations of this article
104Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

T lymphocytes are key contributors to the acute phase of cerebral ischemia reperfusion injury, but the relevant T cell-derived mediators of tissue injury remain unknown. Using a mouse model of transient focal brain ischemia, we report that IL-21 is highly up-regulated in the injured mouse brain after cerebral ischemia. IL-21-deficient mice have smaller infarcts, improved neurological function, and reduced lymphocyte accumulation in the brain within 24 h of reperfusion. Intracellular cytokine staining and adoptive transfer experiments revealed that brain-infiltrating CD4+ T cells are the predominant IL-21 source. Mice treated with decoy IL-21 receptor Fc fusion protein are protected from reperfusion injury. In postmortem human brain tissue, IL-21 localized to perivascular CD4+ T cells in the area surrounding acute stroke lesions, suggesting that IL-21-mediated brain injury may be relevant to human stroke. © 2014 Clarkson et al.

Cite

CITATION STYLE

APA

Clarkson, B. D. S., Ling, C., Shi, Y., Harris, M. G., Rayasam, A., Sun, D., … Fabry, Z. (2014). T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. Journal of Experimental Medicine, 211(4), 595–604. https://doi.org/10.1084/jem.20131377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free